Healthcare Sales & Marketing Network News: Chugai

Searching News Database: Chugai

HSMN NewsFeed - 25 Jun 2024
Halozyme Announces Roche's OCREVUS(R) SC with ENHANZE(R) Receives European Commission Approval for Relapsing and Primary Progressive Multiple Sclerosis
Biopharmaceuticals Neurology Regulatory

HSMN NewsFeed - 18 Jun 2024
Roche receives FDA clearance on its digital pathology solution for diagnostic use
Devices Diagnostics FDA

HSMN NewsFeed - 27 May 2024
Roche And Hitachi High-Tech Extend their 46-Year Partnership, Paving the Way for Further Breakthroughs in Diagnostic Testing
Diagnostics

HSMN NewsFeed - 26 Apr 2022
Halozyme Commences Tender Offer for All Outstanding Shares of Common Stock of Antares Pharma
Biopharmaceuticals Drug Delivery Mergers & Acquisitions

HSMN NewsFeed - 13 Apr 2022
Halozyme to Acquire Antares Pharma to Create a Specialty Product and Drug Delivery Leader
Biopharmaceuticals Drug Delivery Mergers & Acquisitions

HSMN NewsFeed - 25 Mar 2022
Roche announces collaboration with Bristol Myers Squibb to advance personalised healthcare through digital pathology solutions
Diagnostics

HSMN NewsFeed - 15 Dec 2021
Roche Launches the First Infectious Disease Tests and Cobas Omni Utility Channel for Use on the Cobas 5800 System in Countries Accepting the CE Mark
Diagnostics Product Launch

HSMN NewsFeed - 9 Mar 2021
Roche receives FDA approval for VENTANA ALK (D5F3) CDx Assay to identify lung cancer patients eligible for targeted treatment with LORBRENA (lorlatinib)
Diagnostics Oncology FDA

HSMN NewsFeed - 29 Oct 2020
Roche receives FDA approval for the cobas EGFR Mutation Test v2 as the first companion diagnostic test for expanded EGFR TKI therapies in patients with non-small cell lung cancer
Diagnostics Oncology FDA

HSMN NewsFeed - 8 Sep 2020
FDA Approves First NGS-Based Companion Diagnostic for RET Fusion-Positive Non-Small Cell Lung Cancer
Diagnostics Oncology FDA

HSMN NewsFeed - 17 Mar 2020
Roche begins shipments of first 400,000 COVID-19 tests to laboratories across US to begin patient testing under FDA Emergency Use Authorization
Diagnostics Product Launch

HSMN NewsFeed - 23 Aug 2018
Roche receives FDA approval for cobas EGFR Mutation Test v2 as companion diagnostic with IRESSA (gefitinib) in first-line treatment of patients with non-small cell lung cancer (NSCLC)
Diagnostics Oncology FDA

HSMN NewsFeed - 11 Jun 2018
Roche introduces first self-testing device for Warfarin monitoring with built in Bluetooth(R) technology
Devices Monitoring Product Launch

HSMN NewsFeed - 14 May 2018
FDA approves additional claim for Roche cobas Zika test
Diagnostics FDA

HSMN NewsFeed - 16 Apr 2018
Roche receives FDA clearance for cobas(R) CT/NG for cobas(R) 6800/8800 Systems
Diagnostics FDA

HSMN NewsFeed - 8 Mar 2018
Roche launches the new cobas m 511 analyzer, signaling a new era in hematology testing
Diagnostics FDA Product Launch

HSMN NewsFeed - 26 Jul 2017
Roche Launches the Avenio Millisect System for Precise and Efficient Dissection of Tissue Biopsies
Diagnostics Product Launch

HSMN NewsFeed - 17 Jul 2017
Medicenna Bolsters Management Team
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 1 Jun 2017
Roche announces FDA approval of companion diagnostic to identify ALK-positive non-small cell lung cancer patients
Diagnostics Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 1 May 2017
FDA Clears Roche High-Volume Immunoassay Lab Testing Solution to Support Critical Medical Treatment Decisions
Diagnostics FDA

HSMN NewsFeed - 12 Apr 2017
Roche Launches Antibody Test to Aid in Diagnosis of Challenging Prostate Cancer Cases
Diagnostics Oncology Product Launch

HSMN NewsFeed - 24 Jan 2017
FDA Grants Priority Review for Genentech’s Actemra(R) (Tocilizumab) Supplemental Biologics License Application for Giant Cell Arteritis, a Form of Vasculitis
Biopharmaceuticals FDA

HSMN NewsFeed - 22 Dec 2016
Genentech’s Emicizumab for Hemophilia A Meets Primary Endpoint in Phase III Study
Biopharmaceuticals

HSMN NewsFeed - 28 Sep 2016
Assembly Biosciences Announces Key Additions to Microbiome Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Sep 2016
Roche Receives 510(K) Clearance from FDA for Treponema Pallidum Assay to Aid Clinicians in the Diagnosis of Syphilis Infection
Diagnostics FDA

HSMN NewsFeed - 29 Aug 2016
Roche receives FDA Emergency Use Authorization for Zika PCR Test
Biopharmaceuticals FDA

HSMN NewsFeed - 25 May 2016
Roche announces the first FDA-approved CMV test for use in hematopoietic stem cell transplant recipients
Diagnostics FDA

HSMN NewsFeed - 23 Mar 2016
Roche Submits Filing to FDA For cobas(R) Procalcitonin (Pct) Assay to Help Clinicians Assess Response of Septic Patients to Treatment
Biopharmaceuticals FDA

HSMN NewsFeed - 21 Mar 2016
FDA approves expanded use of Roche hepatitis C virus RNA test as aid in diagnosis
Diagnostics FDA

HSMN NewsFeed - 21 Dec 2015
Roche receives FDA approval for HIV-1 viral load test on the cobas(R) 6800/8800 Systems
Diagnostics HIV/AIDS FDA

HSMN NewsFeed - 1 Dec 2015
Roche And Upsher-Smith Announce License Agreement To Develop Novel VAP-1 Inhibitor
Biopharmaceuticals Licensing

HSMN NewsFeed - 4 Sep 2015
U.S. FDA Grants Breakthrough Therapy Designation for Genentech’s Investigational Medicine ACE910 for People With Hemophilia A With Factor VIII Inhibitors
Biopharmaceuticals FDA

HSMN NewsFeed - 26 May 2015
Roche receives FDA clearance for the cobas(R) Cdiff Test to detect Clostridium difficile
Diagnostics FDA

HSMN NewsFeed - 14 May 2015
EPIRUS Biopharmaceuticals and mAbxience Sign Latin America Distribution Deal for Infliximab Biosimilar, BOW015
Biopharmaceuticals Distribution

HSMN NewsFeed - 11 May 2015
Roche Receives FDA Approval for cobas(R) KRAS Mutation Test
Diagnostics Oncology FDA

HSMN NewsFeed - 26 Jan 2015
Roche receives FDA clearance for next generation cobas MRSA/SA Test
Diagnostics FDA

HSMN NewsFeed - 29 Dec 2014
Roche receives FDA Emergency Use Authorization for the LightMix(R) Ebola Zaire rRT-PCR Test
Diagnostics

HSMN NewsFeed - 25 Apr 2014
Chugai Pharma USA Announces Appointment of Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Apr 2014
FDA Approves Roche's HPV Test for First-Line Primary Screening for Cervical Cancer
Diagnostics Oncology FDA

HSMN NewsFeed - 10 May 2013
Curis Announces Approval of Erivedge(R) in Australia
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 26 Apr 2013
Curis Announces Erivedge(R) Receives Positive CHMP Opinion for Conditional Approval in European Union
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 18 Feb 2013
Roche and Chiasma Announce Collaboration to Develop and Commercialize Chiasma's Octreolin(R) for Acromegaly and Neuroendocrine Tumors
Biopharmaceuticals Endocrinology Licensing

HSMN NewsFeed - 28 Nov 2012
Curis Announces $30 Million Secured Debt Financing to Support Development of Proprietary Pipeline
Biopharmaceuticals Oncology

HSMN NewsFeed - 12 Oct 2012
FDA Approves Expanded Indication for ACTEMRA(R) in Rheumatoid Arthritis
Biopharmaceuticals FDA

HSMN NewsFeed - 1 Oct 2012
Roche Diagnostics ACCU-CHEK Combo Insulin Pump System Now Available in United States
Devices Monitoring Drug Delivery Endocrinology

HSMN NewsFeed - 27 Jul 2012
Roche and AREVA Med Join Forces in the Fight Against Cancer and Create a Novel Radio-Immunotherapy
Biopharmaceuticals Oncology

HSMN NewsFeed - 27 Jul 2012
Genentech Reports Second Positive Study of ACTEMRA(R) Given by Subcutaneous Injection to Patients with Rheumatoid Arthritis
Biopharmaceuticals

HSMN NewsFeed - 17 Jul 2012
Biodesix Appoints Vice President of Clinical Development & Medical Affairs
Diagnostics Personalized Medicine Personnel

HSMN NewsFeed - 16 May 2012
Roche and HYCOR Sign Global Distribution Agreement
Diagnostics Distribution

HSMN NewsFeed - 3 May 2012
Genentech Reports Positive Study of ACTEMRA Given by Subcutaneous Injection
Biopharmaceuticals

HSMN NewsFeed - 2 Mar 2012
Genentech’s ACTEMRA(R) Monotherapy Showed Superior Improvement in Rheumatoid Arthritis Signs and Symptoms Versus Adalimumab Monotherapy
Biopharmaceuticals

HSMN NewsFeed - 30 Jan 2012
Curis Announces FDA Approval of Erivedge(TM) (vismodegib) Capsule as First Treatment for Advanced Basal Cell Carcinoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 27 Jan 2012
Roche commences tender offer for Illumina, Inc. for $44.50 per share in cash
Diagnostics Personalized Medicine Mergers & Acquisitions

HSMN NewsFeed - 22 Dec 2011
Response Genetics Names Thomas A. Bologna Chairman and CEO
Diagnostics Personnel

HSMN NewsFeed - 5 Dec 2011
Roche Acquires Verum Diagnostica GmbH as Part of Plan to Develop Comprehensive Coagulation Testing Portfolio for Diagnostic Laboratories
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 9 Nov 2011
FDA Accepts Genentech’s New Drug Application For Vismodegib in Advanced Form of Skin Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 15 Sep 2011
Elan Announces Board of Director Changes
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 12 Sep 2011
Genentech Submits New Drug Application to FDA for Vismodegib for Rare Form of Advanced Skin Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 19 Jul 2011
Roche acquires mtm laboratories AG, expanding offering in cervical cancer testing
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 19 Apr 2011
FDA Approves Rituxan Plus a Steroid for Use in Severe Forms of Vasculitis
Biopharmaceuticals FDA

HSMN NewsFeed - 15 Apr 2011
FDA Approves ACTEMRA(R) (tocilizumab) for the Treatment of Systemic Juvenile Idiopathic Arthritis (SJIA)
Biopharmaceuticals FDA

HSMN NewsFeed - 28 Mar 2011
Janet Hammond Joins Roche as Vice President, Translational Medicine - Virology
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Mar 2011
Genentech Announces Positive Pivotal Phase II Results for Hedgehog Pathway Inhibitor in Advanced Basal Cell Carcinoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 5 Jan 2011
FDA Grants Supplemental Approval for ACTEMRA(R) (tocilizumab)
Biopharmaceuticals FDA

HSMN NewsFeed - 15 Nov 2010
NT-proBNP Guided Therapy Keeps Heart Failure Patients out of the Hospital Through a Reduction in Cardiovascular Events
Biopharmaceuticals Cardiology

HSMN NewsFeed - 29 Oct 2010
Roche Introduces Immunoassay Module for cobas(R) 8000 Modular Analyzer Series In U.S.
Diagnostics

HSMN NewsFeed - 22 Sep 2010
Roche Receives FDA Approval for Second-Generation Hepatitis B Viral Load Test
Diagnostics FDA

HSMN NewsFeed - 13 Sep 2010
Roche Receives FDA Clearance for U.S. Launch of cobas 8000 Modular Analyzer Series for High-Volume Laboratory Testing
Devices Diagnostics FDA

HSMN NewsFeed - 26 Jul 2010
Roche Receives FDA Clearance for CoaguChek XS Pro system With Bar Code Reader for PT/INR Testing at the Point of Care
Diagnostics FDA

HSMN NewsFeed - 26 Jul 2010
Karen Lackey Named Vice President and Head of Medicinal Chemistry at Roche
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Jun 2010
FDA Approves New Roche Dual-PCR Target HIV-1 Test
Diagnostics FDA HIV/AIDS

HSMN NewsFeed - 28 May 2010
Roche Diagnostics Receives FDA Approval for Qualitative Anti-HCV Immunoassay Test on Three Analyzer Platforms
Diagnostics FDA

HSMN NewsFeed - 19 May 2010
Caris Life Sciences Names Jonathan Knowles, Ph.D., Chief Scientific Officer
Diagnostics Personalized Medicine Personnel

HSMN NewsFeed - 19 May 2010
Roche and Biogen Idec Announce Their Decision to Discontinue the ocrelizumab Clinical Development Programme in Patients with Rheumatoid Arthritis
Biopharmaceuticals

HSMN NewsFeed - 16 Mar 2010
Genentech Submits Supplemental Biologics License Application for ACTEMRA(R) (tocilizumab) for Prevention of Structural Joint Damage and Improvement of Physical Function in Rheumatoid Arthritis
Biopharmaceuticals FDA

HSMN NewsFeed - 17 Feb 2010
Roche Collaborates with Merck on Developmental Test for Cancer-Related Gene Mutation
Diagnostics Oncology

HSMN NewsFeed - 19 Jan 2010
OraSure Technologies and Roche Diagnostics Sign Worldwide Commercialization Agreement for Fully Automated Oral Fluid Drugs of Abuse Assays
Diagnostics

HSMN NewsFeed - 9 Jan 2010
FDA Approves ACTEMRA(R) (tocilizumab) for the Treatment of Moderately to Severely Active Rheumatoid Arthritis
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Dec 2009
Caris Diagnostics Names New Vice Chairman and Board Member, Dr. Jonathan Knowles
Diagnostics Personnel

HSMN NewsFeed - 16 Dec 2009
Roche Licenses First-in-Class Treatments for Chronic Pain to Afferent Pharmaceuticals; Afferent Secures $23 Million in Series A Financing
Biopharmaceuticals Licensing Venture Capital

HSMN NewsFeed - 7 Dec 2009
Phase III Data Showed Rituxan Plus Chemotherapy Improved Survival in Patients With Most Common Form of Adult Leukemia
Biopharmaceuticals Oncology

HSMN NewsFeed - 2 Dec 2009
FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus
Diagnostics FDA

HSMN NewsFeed - 17 Sep 2009
Phase III Study Showed Patients Lived Longer Without Low-Grade Lymphoma Progressing When Rituxan Was Used First-Line for Maintenance
Biopharmaceuticals Oncology

HSMN NewsFeed - 31 Aug 2009
FDA Approves Valcyte(R) (valganciclovir hydrochloride) to Prevent Cytomegalovirus (CMV) Disease in Pediatric Patients Who Receive Heart or Kidney Transplants
Biopharmaceuticals FDA

HSMN NewsFeed - 26 May 2009
Two-Year Data Reinforce Effect of ACTEMRA(R) (tocilizumab) in Inhibiting Progression of Joint Damage and Improving Physical Function in Rheumatoid Arthritis Patients
Biopharmaceuticals

HSMN NewsFeed - 12 May 2009
Roche Announces Long-Term Commitment to Tackle Growing Epidemic of Diabetes
Biopharmaceuticals Diagnostics Monitoring Endocrinology

HSMN NewsFeed - 5 May 2009
CytRx Appoints Jaisim Shah Chief Business Officer and Senior Vice President of Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Apr 2009
Roche Announces Collaboration to Investigate New Treatment Strategy With Tarceva in Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 20 Apr 2009
Newly Published Study Shows That Re-Treatment With Pegasys(R) (Peginterferon Alfa-2a) Provides Hepatitis C Patients With a Second Chance for a Cure
Biopharmaceuticals

HSMN NewsFeed - 2 Apr 2009
Roche to Introduce New LightCycler(R) MRSA Advanced Test in the EU
Diagnostics Regulatory

HSMN NewsFeed - 26 Mar 2009
Roche Completes Tender Offer for Genentech
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 12 Mar 2009
Roche and Genentech Reach a Friendly Agreement to Combine the Two Organizations and Create a Leader in Healthcare Innovation
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 11 Mar 2009
Phase III Study of Rituxan in Lupus Nephritis Did Not Meet Primary Endpoint
Biopharmaceuticals

HSMN NewsFeed - 2 Mar 2009
Rockwell Medical Technologies, Inc. Appoints Richard Yocum, M.D. as VP of Drug Development and Medical Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Feb 2009
Romark and Chugai Pharmaceutical Enter Into Exclusive Licensing Agreement for Nitazoxanide in Japan
Biopharmaceuticals Licensing

HSMN NewsFeed - 9 Feb 2009
Roche Commences Tender Offer for Genentech for US$86.50 Per Share in Cash
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 30 Jan 2009
Roche Intends to Commence Tender Offer to Acquire All Shares of Genentech for US$ 86.50 Per Share in Cash
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 31 Dec 2008
FDA Approves Most Comprehensive System to Test Donated Blood for HIV, Hepatitis B & Hepatitis C
Diagnostics FDA

HSMN NewsFeed - 16 Dec 2008
Fujirebio Diagnostics and Roche Diagnostics Sign Agreement for New Ovarian Cancer Test
Diagnostics Oncology Licensing

HSMN NewsFeed - 6 Dec 2008
Rituxan in Combination with Chemotherapy Improves Progression-Free Survival in Difficult-to-Treat Form of Blood Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 4 Dec 2008
European Commission Approval of New Indication for Roche's Pegasys(R) (peginterferon alfa-2a) Offers Hepatitis C Patients a Second Chance for a Cure
Biopharmaceuticals Regulatory

HSMN NewsFeed - 4 Dec 2008
Roche and FDA Agree on Pathway Towards U.S. Approval of ACTEMRA(R) (tocilizumab)
Biopharmaceuticals

HSMN NewsFeed - 2 Dec 2008
Ellen McDonald Joins Regado Biosciences as Senior Vice President of Business Operations and Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Nov 2008
Roche signs definitive agreement to acquire Memory Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 25 Nov 2008
Roche Signs Definitive Agreement to Acquire Memory Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 5 Sep 2008
Questcor Strengthens Management Team's Manufacturing and Commercial Operations Capabilities
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Aug 2008
Monoclonal Antibody Sales to Almost Double in Coming Years
Biopharmaceuticals

HSMN NewsFeed - 8 Aug 2008
Roche's 454 Sequencing System Used to Determine the Complete Neanderthal Mitochondrial Genome, Establishing When Humans and Neanderthals Diverged
Diagnostics

HSMN NewsFeed - 4 Aug 2008
David J. Mazzo, Ph.D., Joins Regado Biosciences as President and CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Aug 2008
Lung Cancer Epidemic Looming in Asia?
Biopharmaceuticals Oncology

HSMN NewsFeed - 28 Jul 2008
Roche and Response Biomedical Corporation Aim to Reduce 'Vein-to-Brain' Time with New Point-of-Care Cardiac Tests
Diagnostics Cardiology

HSMN NewsFeed - 23 Jul 2008
Roche starts acquisition process of ARIUS to gain access to new screening platform for antibody therapeutics
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 21 Jul 2008
Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 26 Jun 2008
European Approval for Roche's Pegasys Personalises Treatment for a Subgroup of Hepatitis C Patients: Chance for Cure With Only Four Months of Treatment
Biopharmaceuticals Regulatory

HSMN NewsFeed - 24 Jun 2008
Stason Pharmaceuticals, Inc. Appoints Diana Wood as Vice President, Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Jun 2008
ACTEMRA(R) (tocilizumab) Significantly Reduces Rheumatoid Arthritis Signs and Symptoms Regardless of Previous Therapy in Two New Global Studies
Biopharmaceuticals

HSMN NewsFeed - 13 Jun 2008
New Roche Chlamydia Test Approved for Use in European Union
Diagnostics Regulatory

HSMN NewsFeed - 29 Apr 2008
Genentech and Biogen Idec Announce Top-Line Results from Phase II/III Clinical Study of Rituxan in Systemic Lupus Erythematosus
Biopharmaceuticals

HSMN NewsFeed - 8 Apr 2008
Roche Diagnostics Expands Availability of HCV Immunoassay
Diagnostics Regulatory

HSMN NewsFeed - 20 Mar 2008
International ACTEMRA Rheumatoid Arthritis Study Highlighted in The Lancet
Biopharmaceuticals

HSMN NewsFeed - 4 Mar 2008
Roche Statement Regarding Tamiflu U.S. Label Revision
Biopharmaceuticals FDA

HSMN NewsFeed - 19 Feb 2008
Roche Completes Tender Offer for Ventana Shares
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 25 Jan 2008
Genentech and Biogen Idec Announce Positive Results from a Phase III Trial of Rituxan in Patients with Rheumatoid Arthritis Who Inadequately Responded to Methotrexate
Biopharmaceuticals

HSMN NewsFeed - 22 Jan 2008
Roche to Acquire Ventana for $89.50 per share
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 14 Dec 2007
OSI Pharmaceuticals Announces Launch Date of Tarceva(R) (erlotinib) in Japan
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 21 Nov 2007
Roche Submits Application for FDA Approval of ACTEMRA(R) for the Treatment of Rheumatoid Arthritis
Biopharmaceuticals

HSMN NewsFeed - 13 Nov 2007
NPS Pharmaceuticals Announces Senior Management Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Nov 2007
Roche Confirms Commencement of Due Diligence with Ventana
Diagnostics

HSMN NewsFeed - 29 Oct 2007
Roche Extends Tender Offer for Ventana
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 22 Oct 2007
Tarceva(R) (erlotinib) Earns Approval for Lung Cancer Patients in Japan
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 26 Sep 2007
Exclusive Agreement Announced Between Quidel Corporation and Roche Pharma AG
Diagnostics

HSMN NewsFeed - 19 Sep 2007
Roche Extends Tender Offer for Ventana
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 10 Sep 2007
Aspreva Provides Update On Lupus Nephritis Development Program
Biopharmaceuticals

HSMN NewsFeed - 4 Sep 2007
Roche's Tarceva(R) Delivers Longer Life for Lung Cancer Patients
Biopharmaceuticals Oncology

HSMN NewsFeed - 28 Aug 2007
FDA Approves New Roche West Nile Virus Blood Screening Test
Diagnostics FDA

HSMN NewsFeed - 28 Aug 2007
Aspreva and Roche Update CellCept Agreement
Biopharmaceuticals

HSMN NewsFeed - 21 Aug 2007
Roche Extends Tender Offer for Ventana
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 26 Jul 2007
Roche Extends Tender Offer for Ventana
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 25 Jul 2007
Roche Announces Expiration of HSR Waiting Period for Ventana Offer
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 16 Jul 2007
Roche Executes Fastest Market Penetration with HIV Viral Load Monitoring Test, COBAS(R) AmpliPrep(R) /COBAS(R) TaqMan(R) HIV-1
Diagnostics HIV/AIDS

HSMN NewsFeed - 11 Jul 2007
Roche Says Offer for Ventana Medical Systems, Inc. is Full and Fair
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 10 Jul 2007
ACTEMRA(TM) (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
Biopharmaceuticals

HSMN NewsFeed - 9 Jul 2007
Roche and Alnylam Form Major Alliance on RNAi Therapeutics
Biopharmaceuticals

HSMN NewsFeed - 27 Jun 2007
Roche Commences Tender Offer for Ventana for $75 Per Share in Cash
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 27 Jun 2007
Aspreva and Roche announce preliminary results for phase III study evaluating CellCept in lupus nephritis
Biopharmaceuticals

HSMN NewsFeed - 26 Jun 2007
Roche Completes Acquisition of BioVeris
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 25 Jun 2007
Roche Makes Offer to Acquire Ventana for $75.00 Per Share in Cash
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 19 Jun 2007
New Study Demonstrates Significant Economic and Clinical Value of NT-proBNP Testing for the Management of Heart Failure
Diagnostics Cardiology

HSMN NewsFeed - 15 Jun 2007
ACTEMRA(TM) (tocilizumab) Significantly Improves Symptoms of Rheumatoid Arthritis Compared to a Current Standard of Care
Biopharmaceuticals

HSMN NewsFeed - 13 Jun 2007
Latest Data Show MabThera(R) Provides Significant and Sustained Relief From Signs and Symptoms of Rheumatoid Arthritis
Biopharmaceuticals

HSMN NewsFeed - 29 May 2007
454 Life Sciences Announces the Completion of its Acquisition by Roche
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 23 May 2007
Roche Diagnostics Announces Successful Resolution of Urgent Medical Device Correction Of CoaguChek PT Test Strips Used in Anticoagulation Monitoring
Diagnostics

HSMN NewsFeed - 10 May 2007
La Jolla Pharmaceutical Company Names Niv Caviar Chief Business and Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 May 2007
AEterna Zentaris Bolsters Management Team with Two Key Positions Named
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 May 2007
Rituxan(R) Phase II Data in Patients with Relapsing-Remitting Multiple Sclerosis Presented at the American Academy of Neurology
Biopharmaceuticals Neurology

HSMN NewsFeed - 26 Mar 2007
AEterna Zentaris Announces Appointment of New President and CEO
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 20 Feb 2007
Cobalis Appoints Three Pharmaceutical Industry Executives to Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Feb 2007
New CoaguChek XS System Offers Healthcare Providers Greater Flexibility and Control for Anticoagulation Monitoring at the Point of Care
Diagnostics

HSMN NewsFeed - 5 Feb 2007
Roche Continues to Strengthen Research and Development
Biopharmaceuticals

HSMN NewsFeed - 24 Jan 2007
pSivida appoints Boston based Managing Director
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 24 Jan 2007
Phase III ACTEMRA(TM) (tocilizumab) Study Results Demonstrate Significant Improvement in Signs and Symptoms of Patients with Rheumatoid Arthritis
Biopharmaceuticals

HSMN NewsFeed - 17 Jan 2007
Roche Diagnostics Submits West Nile Virus Blood Screening Test to FDA
Diagnostics

HSMN NewsFeed - 15 Jan 2007
Roche Diagnostics Submits Hepatitis C Viral Load Monitoring Test to FDA
Diagnostics FDA

HSMN NewsFeed - 4 Jan 2007
Roche and Synosis Therapeutics Announce Partnership to Explore Potential of Five Compounds Targeting the Central Nervous System
Biopharmaceuticals

HSMN NewsFeed - 5 Dec 2006
Halozyme and Roche Enter Agreement for the Application of Enhanze, A Novel Technology to Improve Drug Delivery
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 13 Nov 2006
New Study Shows ACTEMRA(TM) (tocilizumab) Significantly Improves Remission Rates in Patients with Rheumatoid Arthritis
Biopharmaceuticals

HSMN NewsFeed - 4 Oct 2006
Roche Diagnostics and OraSure Technologies Sign Letter of Intent to Develop Fully Automated Oral Fluid Drugs of Abuse Assays
Diagnostics

HSMN NewsFeed - 4 Oct 2006
Plexxikon and Roche Enter Partnership to Develop Targeted Cancer Therapeutic Medicine PLX4032
Biopharmaceuticals Oncology

HSMN NewsFeed - 3 Oct 2006
Regeneron Names Peter Powchik, M.D., Senior Vice President of Clinical Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Oct 2006
Alert for BD Logic(R) Meter Users: Roche Diagnostics Offers ACCU-CHEK(R) Blood Glucose Systems
Diagnostics Endocrinology

HSMN NewsFeed - 2 Oct 2006
Patients With HER2-Positive Breast Cancer Significantly Benefit From Addition of Xeloda to Herceptin and Taxotere Therapy
Biopharmaceuticals Oncology

HSMN NewsFeed - 29 Sep 2006
FDA Approves Two New Indications for Rituxan(R) in Patients With Non-Hodgkin's Lymphoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 27 Sep 2006
Chugai Pharmaceutical to Establish an Oncology Unit
Biopharmaceuticals Oncology

HSMN NewsFeed - 17 Sep 2006
Women More Likely to Stay on Once-Monthly Boniva(R) Versus Once-Weekly Osteoporosis Medicines
Biopharmaceuticals

HSMN NewsFeed - 12 Sep 2006
Chugai Announces Co-Development and Co-Marketing Agreement with Taisho Pharmaceutical for the Antiresorptive Bisphosphonate R484
Biopharmaceuticals Licensing

HSMN NewsFeed - 7 Sep 2006
Xenical(R) Shown to Improve Control of Blood Glucose Levels in People With Type 2 Diabetes Beyond Impact of Weight Loss Alone
Biopharmaceuticals

HSMN NewsFeed - 10 Jul 2006
Cardinal Health Signs Agreement With Roche to Manufacture Tamiflu(R)
Biopharmaceuticals

HSMN NewsFeed - 22 Jun 2006
Analysis of Phase III Study Showed Rituxan(R) Plus Methotrexate Reduced Joint Damage in Rheumatoid Arthritis Patients Who Respond Inadequately to TNF Antagonist Therapies
Biopharmaceuticals

Return to NewsFeed

Additional items found! 125

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 125 additional stories matching:
Chugai
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.